Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Coronary intervention (PCI) · New Jersey | Coronary intervention (PCI) · New York | |
|---|---|---|
| Surgeons, 2024 | 172 | 245 |
| Medicare fee-for-service cases | 6,009 | 13,378 |
| Growth since 2019 (Medicare FFS) | −4.6%/yr | −4.1%/yr |
| Forecast cases (Medicare FFS) | 7,900 in 2030 | 13,900 in 2030 |
| Forecast growth | +4.7%/yr to 2030 | +0.6%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 4.9 | 5.9 |
| Medicare Advantage share | 45% | 57% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 35 | 55 |
| Top 10 surgeons' share | 17% | 25% |
| Surgeons growing | 8 | 34 |
| New since the base year | 30 | 46 |
| Likely to stop billing it | 10 by 2026 | 19 by 2026 |
| Forecast miss, 1 year (procedure) | 4% | 4% |
| Company payments per surgeon | $2,795 | $13K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.